marketcaparena
Search

    CLPT

    ClearPoint Neuro, Inc.

    Company overview

    Market capitalization
    $467.02M
    Employees
    172
    Latest publication
    2026-09-29
    About ClearPoint Neuro, Inc.

    ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue12,128,000USD10,410,000USD8,861,000USD9,215,000USD8,485,000USD7,771,000USD8,122,000USD7,858,000USD
    Cost Of Revenue4,579,000USD4,006,000USD3,261,000USD3,659,000USD3,353,000USD3,009,000USD3,275,000USD2,870,000USD
    Gross Profit7,549,000USD6,404,000USD5,600,000USD5,556,000USD5,132,000USD4,762,000USD4,847,000USD4,988,000USD
    Research Development4,522,000USD3,237,000USD3,452,000USD3,829,000USD3,379,000USD3,332,000USD3,315,000USD3,120,000USD
    Selling General Administrative4,997,000USD5,842,000USD3,186,000USD3,388,000USD4,082,000USD3,229,000USD3,155,000USD2,773,000USD
    Selling And Marketing Expenses6,715,000USD4,770,000USD3,838,000USD4,019,000USD3,834,000USD3,805,000USD3,549,000USD3,834,000USD
    Total Operating Expenses16,027,000USD13,449,000USD10,876,000USD11,236,000USD11,295,000USD10,366,000USD10,019,000USD9,727,000USD
    Operating Income-8,478,000USD-7,045,000USD-5,276,000USD-5,680,000USD-6,163,000USD-5,604,000USD-5,172,000USD-4,739,000USD
    Interest Income351,000USD———151,000USD226,000USD209,000USD326,000USD
    Interest Expense1,382,000USD703,000USD543,000USD80,000USD0USD———
    Net Interest Income-1,031,000USD-703,000USD-543,000USD-80,000USD151,000USD226,000USD209,000USD326,000USD
    Income Before Tax-9,544,000USD-7,782,000USD-5,883,000USD-5,812,000USD-6,008,000USD-5,386,000USD-4,974,000USD-4,408,000USD
    Income Tax Expense8,000USD4,000USD8,000USD25,000USD18,000USD-430,724USD——
    Tax Provision8,000USD4,000USD8,000USD25,000USD18,000USD—14,000USD15,000USD
    Net Income-9,552,000USD-7,786,000USD-5,891,000USD-5,837,000USD-6,026,000USD-5,386,000USD-4,974,000USD-4,408,000USD
    Net Income From Continuing Ops-9,552,000USD-7,786,000USD-5,891,000USD-5,837,000USD-6,026,000USD-5,386,000USD-4,974,000USD-4,408,000USD
    Ebit-8,478,000USD-7,045,000USD-5,340,000USD-5,732,000USD-6,163,000USD-5,604,000USD-5,172,000USD-4,739,000USD
    Ebitda-7,365,000USD-6,194,000USD-5,274,000USD-5,106,000USD-5,829,000USD-5,133,000USD-4,677,000USD-4,276,000USD
    Depreciation And Amortization1,113,000USD851,000USD66,000USD626,000USD334,000USD471,000USD495,000USD463,000USD
    Reconciled Depreciation1,113,000USD851,000USD426,000USD626,000USD334,000USD471,000USD495,000USD463,000USD
    Total Other Income Expense Net-1,066,000USD-737,000USD-607,000USD-132,000USD155,000USD218,000USD198,000USD331,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue36,971,000USD31,390,000USD23,955,000USD20,551,000USD16,299,000USD12,829,000USD11,217,000USD7,353,266USD
    Cost Of Revenue14,279,000USD12,268,000USD10,341,000USD7,020,000USD5,176,000USD3,709,000USD3,942,000USD2,433,069USD
    Gross Profit22,692,000USD19,122,000USD13,614,000USD13,531,000USD11,123,000USD9,120,000USD7,275,000USD4,920,197USD
    Research Development13,897,000USD12,392,000USD11,709,000USD10,894,000USD9,281,000USD4,686,000USD2,810,000USD2,310,139USD
    Selling General Administrative16,498,000USD11,998,000USD11,756,000USD9,611,000USD7,999,000USD5,270,000USD4,303,000USD4,325,786USD
    Selling And Marketing Expenses16,461,000USD14,478,000USD12,595,000USD9,358,000USD7,217,000USD5,384,000USD4,756,000USD3,532,040USD
    Total Operating Expenses46,856,000USD38,868,000USD36,060,000USD29,863,000USD24,497,000USD15,340,000USD11,869,000USD10,167,965USD
    Operating Income-24,164,000USD-19,746,000USD-22,446,000USD-16,332,000USD-13,374,000USD-6,220,000USD-4,594,000USD-5,247,768USD
    Interest Income1,213,000USD872,000USD386,000USD———955,170USD916,060USD
    Interest Expense2,388,000USD518,000USD386,000USD81,000USD973,000USD1,444,000USD955,000USD980,383USD
    Net Interest Income-1,175,000USD872,000USD379,000USD-81,000USD-973,000USD-1,444,000USD-955,166USD-980,383USD
    Income Before Tax-25,485,000USD-18,914,000USD-22,089,000USD-16,435,000USD-14,410,000USD-6,782,000USD-5,540,000USD-6,163,469USD
    Income Tax Expense55,000USD-18,914,000USD1,289,105USD103,000USD910,000USD2,326,000USD964,220USD64,682USD
    Tax Provision55,000USD12,000USD——————
    Net Income-25,540,000USD-18,914,000USD-22,089,000USD-16,435,000USD-14,410,000USD-6,782,000USD-5,540,000USD-6,163,469USD
    Net Income From Continuing Ops-25,540,000USD-18,914,000USD-21,855,000USD-16,435,000USD-14,410,000USD-6,782,000USD-5,539,790USD-6,163,469USD
    Ebit-24,164,000USD-19,746,000USD-22,446,000USD-16,354,000USD-13,437,000USD-5,338,000USD-4,585,000USD-5,183,090USD
    Ebitda-21,927,000USD-17,843,000USD-20,989,000USD-15,577,000USD-12,745,000USD-4,788,000USD-4,334,000USD-5,073,651USD
    Depreciation And Amortization2,237,000USD1,903,000USD1,457,000USD777,000USD692,000USD550,000USD251,000USD109,439USD
    Reconciled Depreciation2,237,000USD1,903,000USD1,186,000USD777,000USD159,000USD550,000USD250,560USD109,439USD
    Total Other Income Expense Net-1,321,000USD832,000USD357,000USD-103,000USD-1,036,000USD-562,000USD-946,000USD-915,701USD
    Non Operating Income Net Other———-22,000USD-63,000USD882,000USD——
    Net Income Applicable To Common Shares———-16,435,000USD-14,410,000USD-6,782,000USD-5,540,000USD-6,163,469USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets93,416,000USD97,747,000USD60,357,000USD62,869,000USD30,070,000USD39,189,000USD40,193,000USD52,574,000USD
    Intangible Assets13,419,000USD13,922,000USD——565,000USD484,000USD612,000USD758,000USD
    Other Current Assets2,049,000USD2,055,000USD2,525,000USD1,897,000USD1,594,000USD1,683,000USD1,823,000USD1,154,000USD
    Total Liab74,575,000USD69,727,000USD44,483,000USD43,126,000USD10,083,000USD13,800,000USD11,192,000USD20,442,000USD
    Total Stockholder Equity18,841,000USD28,020,000USD15,874,000USD19,743,000USD19,987,000USD25,389,000USD29,001,000USD32,132,000USD
    Other Current Liab6,916,000USD8,815,000USD5,264,000USD4,159,000USD3,454,000USD6,335,000USD4,811,000USD4,298,000USD
    Common Stock300,000USD294,000USD284,000USD284,000USD280,000USD276,000USD276,000USD276,000USD
    Capital Stock300,000USD294,000USD284,000USD284,000USD280,000USD276,000USD276,000USD276,000USD
    Retained Earnings-226,462,000USD-216,910,000USD-209,124,000USD-203,233,000USD-197,396,000USD-191,370,000USD-185,984,000USD-181,010,000USD
    Good Will7,472,000USD7,472,000USD———0USD——
    Cash35,593,000USD45,923,000USD38,221,000USD41,541,000USD12,387,000USD20,104,000USD21,573,000USD32,845,000USD
    Cash And Short Term Investments35,593,000USD45,923,000USD38,221,000USD41,541,000USD12,387,000USD20,104,000USD21,573,000USD32,845,000USD
    Total Current Assets54,877,000USD63,600,000USD51,329,000USD53,991,000USD24,214,000USD33,363,000USD34,330,000USD46,556,000USD
    Total Current Liabilities9,480,000USD10,765,000USD8,053,000USD7,398,000USD6,866,000USD10,353,000USD7,554,000USD16,694,000USD
    Net Debt27,995,000USD12,309,000USD-2,476,000USD-6,085,000USD-8,949,000USD-16,536,000USD-17,879,000USD-19,048,000USD
    Short Term Debt234,000USD694,000USD347,000USD331,000USD578,000USD557,000USD536,000USD10,495,000USD
    Short Long Term Debt Total63,588,000USD58,232,000USD35,745,000USD35,456,000USD3,438,000USD3,568,000USD3,694,000USD13,797,000USD
    Long Term Debt49,644,000USD49,077,000USD29,203,000USD28,845,000USD————
    Net Receivables8,662,000USD7,263,000USD4,000,000USD4,260,000USD3,651,000USD4,713,000USD3,875,000USD4,526,000USD
    Inventory8,573,000USD8,359,000USD6,583,000USD6,293,000USD6,582,000USD6,863,000USD7,059,000USD8,031,000USD
    Accounts Payable2,330,000USD1,256,000USD723,000USD1,531,000USD1,216,000USD1,340,000USD955,000USD822,000USD
    Property Plant Equipment Net16,002,000USD11,051,000USD8,069,000USD8,158,000USD5,143,000USD5,091,000USD4,905,000USD4,875,000USD
    Property Plant Equipment Gross16,002,000USD12,768,000USD8,069,000USD8,158,000USD5,143,000USD6,434,000USD4,905,000USD4,875,000USD
    Accumulated Other Comprehensive Income5,535,000USD5,641,000USD—————0USD
    Common Stock Shares Outstanding29,546,889shares28,315,254shares28,427,574shares28,258,305shares27,718,918shares27,027,692shares27,591,623shares27,468,378shares
    Non Current Assets Total38,539,000USD34,147,000USD9,028,000USD8,878,000USD5,856,000USD5,826,000USD5,863,000USD6,018,000USD
    Non Current Liabilities Total65,095,000USD58,962,000USD36,430,000USD35,728,000USD3,217,000USD3,447,000USD3,638,000USD3,748,000USD
    Non Current Liabilities Other779,000USD489,000USD263,000USD—————
    Non Currrent Assets Other1,646,000USD1,702,000USD959,000USD720,000USD148,000USD251,000USD346,000USD385,000USD
    Net Working Capital45,397,000USD52,835,000USD43,276,000USD46,593,000USD17,348,000USD23,010,000USD26,776,000USD29,862,000USD
    Unclassified Non Current Liabilities14,672,000USD9,396,000USD6,964,000USD6,883,000USD3,217,000USD3,447,000USD3,638,000USD3,748,000USD
    Unclassified Equity239,168,000USD238,701,000USD224,430,000USD222,408,000USD216,823,000USD216,207,000USD214,433,000USD212,590,000USD
    Current Deferred Revenue——1,719,000USD1,377,000USD1,618,000USD2,121,000USD1,252,000USD1,079,000USD
    Short Long Term Debt———————9,979,000USD
    Unclassified Current Liabilities———————-9,979,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets97,747,000USD39,189,000USD42,661,000USD55,490,000USD65,581,000USD29,518,000USD11,927,000USD7,856,833USD
    Intangible Assets13,922,000USD484,000USD1,041,000USD1,028,000USD265,000USD353,000USD——
    Other Current Assets2,055,000USD1,683,000USD1,177,000USD1,723,000USD508,000USD244,000USD358,000USD213,684USD
    Total Liab69,727,000USD13,800,000USD21,488,000USD18,603,000USD16,794,000USD27,141,000USD7,341,000USD6,345,831USD
    Total Stockholder Equity28,020,000USD25,389,000USD21,173,000USD36,887,000USD48,787,000USD2,377,000USD4,586,000USD1,511,002USD
    Other Current Liab8,815,000USD6,335,000USD4,000,000USD4,889,000USD3,141,000USD1,944,000USD1,736,000USD1,506,762USD
    Common Stock294,000USD276,000USD247,000USD246,000USD237,000USD170,000USD152,000USD110,183USD
    Capital Stock294,000USD276,000USD247,000USD246,000USD237,000USD170,000USD152,353USD110,183USD
    Retained Earnings-216,910,000USD-191,370,000USD-172,456,000USD-150,367,000USD-133,932,000USD-119,522,000USD-112,740,000USD-107,199,586USD
    Good Will7,472,000USD0USD——————
    Cash45,923,000USD20,104,000USD23,140,000USD27,615,000USD54,109,000USD20,099,000USD5,696,000USD3,101,133USD
    Cash And Short Term Investments45,923,000USD20,104,000USD23,140,000USD37,489,000USD54,109,000USD20,099,000USD5,696,000USD3,101,133USD
    Total Current Assets63,600,000USD33,363,000USD36,172,000USD51,180,000USD61,892,000USD25,462,000USD10,384,000USD6,654,689USD
    Total Current Liabilities10,765,000USD10,353,000USD7,430,000USD6,788,000USD4,753,000USD3,200,000USD3,833,000USD2,007,690USD
    Net Debt12,309,000USD-16,536,000USD-9,199,000USD-15,629,000USD-41,825,000USD4,021,000USD-3,232,000USD379,508USD
    Short Term Debt694,000USD557,000USD424,000USD561,000USD507,000USD394,000USD114,000USD—
    Short Long Term Debt Total58,232,000USD3,568,000USD13,941,000USD11,986,000USD12,284,000USD24,120,000USD2,464,000USD3,480,641USD
    Long Term Debt49,077,000USD—9,949,000USD9,893,000USD9,838,000USD21,280,000USD2,072,583USD3,480,641USD
    Net Receivables7,263,000USD4,713,000USD3,944,000USD2,665,000USD2,337,000USD1,881,000USD1,090,000USD1,233,896USD
    Inventory8,359,000USD6,863,000USD7,911,000USD9,303,000USD4,938,000USD3,238,000USD3,240,000USD2,105,976USD
    Accounts Payable1,256,000USD1,340,000USD393,000USD272,000USD427,000USD300,000USD966,000USD500,928USD
    Property Plant Equipment Net11,051,000USD5,091,000USD4,953,000USD2,701,000USD2,780,000USD3,055,000USD821,000USD377,706USD
    Property Plant Equipment Gross12,768,000USD6,434,000USD5,898,000USD2,701,000USD2,780,000USD3,055,000USD821,380USD377,706USD
    Accumulated Other Comprehensive Income5,641,000USD—0USD0USD0USD—0USD-1,718,149USD
    Common Stock Shares Outstanding28,315,254shares27,027,692shares24,605,212shares24,181,854shares20,734,236shares15,849,667shares13,155,163shares10,928,213shares
    Non Current Assets Total34,147,000USD5,826,000USD6,489,000USD4,310,000USD3,689,000USD4,056,000USD1,543,000USD1,202,144USD
    Non Current Liabilities Total58,962,000USD3,447,000USD14,058,000USD11,815,000USD12,041,000USD23,941,000USD3,508,000USD4,338,141USD
    Non Current Liabilities Other489,000USD——1,532,000USD1,939,000USD2,446,000USD——
    Non Currrent Assets Other1,702,000USD251,000USD495,000USD581,000USD644,000USD648,000USD722,000USD824,438USD
    Net Working Capital52,835,000USD23,010,000USD28,742,000USD44,392,000USD57,139,000USD22,262,000USD6,550,137USD4,646,999USD
    Unclassified Non Current Liabilities9,396,000USD3,447,000USD4,109,000USD—————
    Unclassified Equity238,701,000USD216,207,000USD193,135,000USD186,762,000USD182,245,000USD121,559,000USD117,021,647USD110,208,371USD
    Current Deferred Revenue—2,121,000USD2,613,000USD1,066,000USD678,000USD562,000USD1,017,000USD350,963USD
    Short Term Investments——0USD9,874,000USD0USD———
    Deferred Long Term Liab———390,000USD264,000USD215,000USD——
    Other Liab———390,000USD264,000USD215,000USD1,158,000USD997,695USD
    Other Assets———581,000USD644,000USD3,737,000USD722,000USD824,438USD
    Net Tangible Assets———35,859,000USD48,522,000USD2,024,000USD4,586,000USD1,511,002USD
    Unclassified Non Current Assets—————-3,737,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-9,552,000USD-7,786,000USD-5,891,000USD-5,837,000USD-6,026,000USD-5,386,000USD-4,974,000USD-4,408,000USD
    Depreciation1,113,000USD-404,000USD426,000USD626,000USD334,000USD471,000USD-197,000USD463,000USD
    Stock Based Compensation2,218,000USD1,981,000USD2,022,000USD2,269,000USD1,908,000USD1,703,000USD1,904,000USD1,796,000USD
    Other Non Cash Items2,690,000USD1,500,000USD357,000USD193,000USD217,000USD211,000USD355,000USD-347,000USD
    Change To Account Receivables-2,019,000USD-765,000USD260,000USD-609,000USD846,000USD-1,049,000USD-401,000USD-602,000USD
    Change To Inventory-125,000USD-87,000USD-498,000USD404,000USD78,000USD309,000USD754,000USD-373,000USD
    Change In Working Capital-2,218,000USD-7,371,000USD-35,000USD197,000USD-2,605,000USD1,758,000USD1,713,000USD-172,000USD
    Total Cash From Operating Activities-7,967,000USD-12,080,000USD-3,121,000USD-2,552,000USD-6,172,000USD-1,243,000USD-1,199,000USD-2,668,000USD
    Capital Expenditures-645,000USD-49,000USD-199,000USD-91,000USD-183,000USD-263,000USD-12,000USD0USD
    Free Cash Flow-8,612,000USD-12,129,000USD-3,320,000USD-2,643,000USD-6,355,000USD-1,506,000USD-1,211,000USD-2,668,000USD
    Total Cashflows From Investing Activities-645,000USD1,088,000USD-199,000USD-91,000USD-183,000USD-263,000USD-12,000USD—
    Total Cash From Financing Activities-1,845,000USD19,564,000USD0USD31,977,000USD-1,362,000USD37,000USD-10,061,000USD160,000USD
    Change In Cash-10,330,000USD8,572,000USD-3,320,000USD29,334,000USD-7,717,000USD-1,469,000USD-11,272,000USD-2,508,000USD
    Begin Period Cash Flow45,923,000USD38,401,000USD41,721,000USD12,387,000USD20,104,000USD21,573,000USD32,845,000USD35,353,000USD
    End Period Cash Flow35,593,000USD46,973,000USD38,401,000USD41,721,000USD12,387,000USD20,104,000USD21,573,000USD32,845,000USD
    Other Cashflows From Financing Activities-1,993,000USD-195,000USD-28,653,000USD28,297,000USD-1,305,000USD71,000USD-10,061,000USD-128,000USD
    Unclassified Operating Cash Flow-2,218,000USD———————
    Net Borrowings—19,433,000USD———0USD——
    Issuance Of Capital Stock—0USD0USD3,263,000USD0USD-34,000USD0USD0USD
    Unclassified Investing Cash Flow—1,137,000USD——————
    Investments——-199,000USD-91,000USD-183,000USD-263,000USD-12,000USD0USD
    Unclassified Financing Cash Flow——28,653,000USD3,369,000USD————
    Sale Purchase Of Stock———311,000USD—4,000USD-61,000USD288,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-25,540,000USD-18,914,000USD-22,089,000USD-16,434,999USD-14,410,000USD-6,782,000USD-5,539,790USD-6,163,469USD
    Depreciation982,000USD1,903,000USD1,514,000USD777,000USD692,000USD553,000USD250,560USD109,439USD
    Stock Based Compensation8,180,000USD6,907,000USD6,079,000USD4,126,000USD2,078,000USD1,090,000USD799,110USD1,231,379USD
    Other Non Cash Items2,267,000USD-245,000USD2,180,000USD3,779,999USD425,000USD893,000USD729,287USD640,029USD
    Change To Account Receivables-268,000USD-1,206,000USD-1,804,000USD-211,000USD627,000USD-791,000USD143,979USD-284,481USD
    Change To Inventory-103,000USD743,000USD1,246,000USD-4,421,000USD-1,714,000USD-25,000USD-1,024,612USD122,220USD
    Change In Working Capital-9,814,000USD1,399,000USD-1,404,000USD-4,289,000USD-1,684,000USD-2,666,000USD911,319USD-383,652USD
    Total Cash From Operating Activities-23,925,000USD-8,950,000USD-13,720,000USD-16,167,000USD-12,697,000USD-7,808,000USD-2,849,514USD-4,630,592USD
    Capital Expenditures-522,000USD-275,000USD-717,000USD-253,000USD-168,000USD-482,000USD-160,190USD-63,490USD
    Free Cash Flow-24,447,000USD-9,225,000USD-14,437,000USD-16,420,000USD-12,865,000USD-8,290,000USD-3,009,704USD-4,694,082USD
    Total Cashflows From Investing Activities615,000USD-275,000USD8,949,000USD-10,736,000USD-168,000USD-482,000USD-160,190USD-63,490USD
    Net Borrowings48,086,000USD-10,000,000USD0USD—0USD22,316,000USD-2,137,000USD-2,000,000USD
    Total Cash From Financing Activities50,179,000USD6,189,000USD296,000USD409,000USD46,875,000USD22,693,000USD5,604,293USD-1,494,616USD
    Issuance Of Capital Stock3,263,000USD16,149,000USD0USD0USD46,785,000USD-1USD7,427,847USD0USD
    Change In Cash26,869,000USD-3,036,000USD-4,475,000USD-26,494,000USD34,010,000USD14,403,000USD2,594,589USD-6,188,698USD
    Begin Period Cash Flow20,104,000USD23,140,000USD27,615,000USD54,109,000USD20,099,000USD5,696,000USD3,101,133USD9,289,831USD
    End Period Cash Flow46,973,000USD20,104,000USD23,140,000USD27,615,000USD54,109,000USD20,099,000USD5,695,722USD3,101,133USD
    Other Cashflows From Financing Activities-1,856,000USD40,000USD506,000USD-336,000USD90,000USD1,000USD313,293USD505,384USD
    Unclassified Investing Cash Flow1,137,000USD—-20,883,000USD—————
    Investments—-275,000USD20,883,000USD-9,590,000USD-168,000USD-482,000USD-160,190USD-63,490USD
    Sale Purchase Of Stock—443,000USD-210,000USD-336,000USD-599,000USD24,634,000USD7,816,640USD505,380USD
    Unclassified Financing Cash Flow—15,706,000USD—1,285,000USD47,816,000USD-24,258,000USD——
    Other Cashflows From Investing Activities——9,666,000USD-893,000USD—-441,000USD-150,000USD—
    Change To Liabilities———1,591,000USD1,450,000USD-896,000USD2,030,000USD-189,537USD
    Dividends Paid———-204,000USD-432,000USD———
    Cash And Cash Equivalents Changes———-26,494,000USD34,010,000USD14,403,000USD——
    Unclassified Operating Cash Flow———-4,126,000USD————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductProduct8,802,000USD0001193125-26-221890
    Q1 2026Quarterly · 2026-03-31ProductServices3,326,000USD0001193125-26-221890
    Q4 2025Quarterly · 2025-12-31ProductProduct7,210,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductServices3,200,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductProduct23,859,000USD0001193125-26-111231
    FY 2025Yearly · 2025-12-31ProductServices13,112,000USD0001193125-26-111231
    Q3 2025Quarterly · 2025-09-30ProductProduct5,361,000USD0001193125-25-270123
    Q3 2025Quarterly · 2025-09-30ProductServices3,500,000USD0001193125-25-270123
    Q2 2025Quarterly · 2025-06-30ProductProduct5,997,000USD0001285550-25-000012
    Q2 2025Quarterly · 2025-06-30ProductServices3,218,000USD0001285550-25-000012
    Q1 2025Quarterly · 2025-03-31ProductProduct5,291,000USD0001193125-26-221890
    Q1 2025Quarterly · 2025-03-31ProductServices3,194,000USD0001193125-26-221890
    Q4 2024Quarterly · 2024-12-31ProductProduct4,573,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductServices3,198,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductProduct18,626,000USD0001193125-26-111231
    FY 2024Yearly · 2024-12-31ProductServices12,764,000USD0001193125-26-111231
    Q3 2024Quarterly · 2024-09-30ProductProduct5,474,000USD0001193125-25-270123
    Q3 2024Quarterly · 2024-09-30ProductServices2,648,000USD0001193125-25-270123
    Q2 2024Quarterly · 2024-06-30ProductProduct4,944,000USD0001285550-25-000012
    Q2 2024Quarterly · 2024-06-30ProductServices2,914,000USD0001285550-25-000012
    FY 2023Yearly · 2023-12-31ProductBiologics And Drug Delivery Disposable Products2,154,000USD0000950170-25-027934
    FY 2023Yearly · 2023-12-31ProductBiologics And Drug Delivery Services And License Fees11,448,000USD0000950170-25-027934
    FY 2023Yearly · 2023-12-31ProductCapital Equipment And Software Services973,000USD0000950170-25-027934
    FY 2023Yearly · 2023-12-31ProductCapital Equipment And Software Systems And Software Products860,000USD0000950170-25-027934
    FY 2023Yearly · 2023-12-31ProductNeurosurgery Navigation And Therapy-Disposable Products7,589,000USD0000950170-25-027934
    FY 2023Yearly · 2023-12-31ProductNeurosurgery Navigation And Therapy-Services931,000USD0000950170-25-027934
    FY 2022Yearly · 2022-12-31ProductBiologics And Drug Delivery Disposable Products3,690,000USD0001285550-24-000031
    FY 2022Yearly · 2022-12-31ProductBiologics And Drug Delivery Services And License Fees5,430,000USD0001285550-24-000031
    FY 2022Yearly · 2022-12-31ProductCapital Equipment And Software Services795,000USD0001285550-24-000031
    FY 2022Yearly · 2022-12-31ProductCapital Equipment And Software Systems And Software Products1,512,000USD0001285550-24-000031
    FY 2022Yearly · 2022-12-31ProductFunctional Neurosurgery Navigation And Therapy Disposable Products7,587,000USD0001285550-24-000031
    FY 2022Yearly · 2022-12-31ProductFunctional Neurosurgery Navigation And Therapy Services1,537,000USD0001285550-24-000031
    FY 2021Yearly · 2021-12-31ProductBiologics And Drug Delivery Disposable Products3,353,000USD0001285550-23-000020
    FY 2021Yearly · 2021-12-31ProductBiologics And Drug Delivery Services And License Fees3,442,000USD0001285550-23-000020
    FY 2021Yearly · 2021-12-31ProductCapital Equipment And Software Services569,000USD0001285550-23-000020
    FY 2021Yearly · 2021-12-31ProductCapital Equipment And Software Systems And Software Products864,000USD0001285550-23-000020
    FY 2021Yearly · 2021-12-31ProductProduct_Functional Neurosurgery Navigation And Therapy Disposable Products7,696,000USD0001285550-23-000020
    FY 2021Yearly · 2021-12-31ProductProduct_Functional Neurosurgery Navigation And Therapy Services375,000USD0001285550-23-000020
    FY 2020Yearly · 2020-12-31ProductProduct8,832,000USD0001285550-22-000003
    FY 2020Yearly · 2020-12-31ProductServices3,997,000USD0001285550-22-000003
    FY 2019Yearly · 2019-12-31ProductBiologics And Drug Delivery Disposable Products1,522,000USD0001171520-21-000138
    FY 2019Yearly · 2019-12-31ProductBiologics And Drug Delivery Services890,000USD0001171520-21-000138
    FY 2019Yearly · 2019-12-31ProductCapital Equipment And Software Services306,000USD0001171520-21-000138
    FY 2019Yearly · 2019-12-31ProductCapital Equipment And Software Systems And Software Products1,356,000USD0001171520-21-000138
    FY 2019Yearly · 2019-12-31ProductProduct_Functional Neurosurgery Navigation And Therapy Disposable Products6,918,000USD0001171520-21-000138
    FY 2019Yearly · 2019-12-31ProductProduct_Functional Neurosurgery Navigation And Therapy Services225,000USD0001171520-21-000138
    FY 2018Yearly · 2018-12-31ProductProduct6,685,020USD0001171520-20-000159
    FY 2018Yearly · 2018-12-31ProductServices668,246USD0001171520-20-000159

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.